about
Acute changes to biomarkers as a consequence of prolonged strenuous runningThe active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirinResidual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistanceIndices of platelet activation and the stability of coronary artery diseaseDifferences in the resting platelet proteome and platelet releasate between healthy children and adults.Application of flow cytometry to platelet disorders.Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia.In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation.Relationship between monocyte-platelet aggregation and endothelial function in middle-aged and elderly adults.First report of elevated monocyte-platelet aggregates in healthy children.The flavonols quercetin and 3',4'-dihydroxyflavonol reduce platelet function and delay thrombus formation in a model of type 1 diabetes.The hemostatic defect of cardiopulmonary bypass.Lectin staining and flow cytometry reveals female-induced sperm acrosome reaction and surface carbohydrate reorganizationFlow cytometry detection of planktonic cells with polycyclic aromatic hydrocarbons sorbed to cell surfaces.Effect of adenosine A2 receptor stimulation on platelet activation-aggregation: differences between canine and human models.Platelets: pleiotropic roles in atherogenesis and atherothrombosis.Hemostatic abnormalities and relationships to metabolic and hormonal status in polycystic ovarian syndrome.Overcoming aspirin treatment failure in diabetes.Imaging flow cytometry in the assessment of leukocyte-platelet aggregates.Acute impact of conventional and eccentric cycling on platelet and vascular function in patients with chronic heart failure.Flow cytometry as a rapid and reliable method to quantify sperm viability in the honeybee Apis mellifera.Impact of commonly prescribed exercise interventions on platelet activation in physically inactive and overweight men.An active, collaborative approach to learning skills in flow cytometry.Measurement of monocyte-platelet aggregates by imaging flow cytometry.Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosis.Gamma tocopherol supplementation prevents exercise induced coagulation and platelet aggregation.Effect of aerobic interval training and caffeine on blood platelet function.Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization.GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention.Platelets from children are hyper-responsive to activation by thrombin receptor activator peptide and adenosine diphosphate compared to platelets from adults.Platelet activation in cystic fibrosis.Aspirin 'resistance': role of pre-existent platelet reactivity and correlation between tests.Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity.The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities.The Acute Effects of Eccentrically-Biased Versus Conventional Weight Training in Older Adults: A Randomised Controlled Cross-Over Study.Acute Impact of Different Exercise Modalities on Arterial and Platelet Function.The effect of haemodilution on antithrombin concentration during cardiac surgery.Beneficial impacts of regular exercise on platelet function in sedentary older adults: Evidence from a randomized 6-month walking trial.Under-nutrition reduces spermatogenic efficiency and sperm velocity, and increases sperm DNA damage in sexually mature male sheep.Inhibition of platelet-mediated arterial thrombosis and platelet granule exocytosis by 3',4'-dihydroxyflavonol and quercetin.
P50
Q27002525-37277B9F-7AE4-4384-90AE-FF612E85F6DAQ28217734-334D85FC-30C6-4026-A538-067CF3851534Q28219288-FB7BB4BF-18A9-4D04-9151-6BD2567BBF4EQ28221194-46E2DFD7-7B09-4C72-8167-1E7AC4CAF8F4Q30009191-00FF86CB-D5C2-45C1-A3F4-EAE74C9E80B0Q33363367-700513C7-2947-4277-924B-957DD9C16BF1Q33397223-C9D129F7-04AD-4A50-A63D-88449F7B69ACQ33399437-0A7C12D3-CDD0-4CAE-982F-819D2D77B7F8Q33740877-22DB6ADB-54B6-499B-A9D9-2097045DA0E0Q34797187-855F4AE6-B152-45A3-B1CE-249980B3674CQ35119269-B29A092F-FFBF-480D-943E-79FC45AB7235Q35747095-73039DA4-5C37-4A16-9787-7945BF76C4E9Q36167988-7BBF479F-6DFF-490B-BB87-00B6F56CA1E4Q36286964-6DB410CE-46A5-40BE-B640-8C06D5BF96D7Q36593731-1C264B7E-C539-4374-8D5E-EC453DFAC797Q37776791-CB84FE98-3A33-4401-9BD9-D753F3F66921Q38002168-08083F47-9A29-4103-A789-6A24508824E9Q38055245-FC1D474F-474E-493E-B538-206045A261ECQ38386740-947CBF11-D60D-489E-9C37-8CF2616CEA42Q38902503-501CE6E9-5BF9-4908-A7E3-F95F6594693FQ39214899-7A2A4AB5-883F-495E-8D85-819083991AD4Q39231240-3AC0F370-9C21-4B5B-BF29-41E2C49EE5D3Q39858578-EDB7CBCE-BF1E-4000-9332-B6111FB21317Q41682933-7F42155A-55CA-4B8C-BC75-5D4F500211B9Q42574744-1F13DC86-98CF-4EE8-80CC-E76FF476E2D9Q43224907-1655F271-C6C5-42D9-B26F-DA95B23772FEQ43817617-BD22AAE2-D9DC-4C5A-9733-F2FF24A15A1AQ44933511-ED3B072A-D8F2-4E83-B56E-28D225A93AD2Q45237822-FB5E8150-96F5-46C0-B774-08F695DC3404Q45247560-B31F89C8-C8D8-45A4-9BC3-992E307D0FAAQ45261261-17D6B657-5241-4193-8C33-8AB1EC550F1CQ46265322-D52D2284-CDC7-42D4-89CC-0A7AFD729331Q46767671-3E11D62C-D368-474E-8655-36EA25439907Q46894672-B94B52A4-EE19-4151-A68A-D1BCC975A931Q47192039-519C7D78-F278-4F24-A8AD-360BED7F9782Q47310570-29C14452-C022-44FA-8762-1390F5733FA9Q51222123-A5DADA5B-A1EA-4E5C-8F7E-A529D55417CCQ52592218-F3F7BB76-AAAA-42E8-9874-5CF003D86AE2Q53833942-8426CE72-6CCF-4B30-8705-0E76A32F9732Q54464910-CE750EFB-639E-4353-91B2-347F31FB9569
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Matthew D. Linden
@ast
Matthew D. Linden
@en
Matthew D. Linden
@es
Matthew D. Linden
@nl
Matthew D. Linden
@sl
type
label
Matthew D. Linden
@ast
Matthew D. Linden
@en
Matthew D. Linden
@es
Matthew D. Linden
@nl
Matthew D. Linden
@sl
prefLabel
Matthew D. Linden
@ast
Matthew D. Linden
@en
Matthew D. Linden
@es
Matthew D. Linden
@nl
Matthew D. Linden
@sl
P106
P1153
7202047808
P21
P31
P496
0000-0002-9126-2166